<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tbl6" position="float">
 <label>Table 6</label>
 <caption>
  <title>Small Molecule Compounds in Research and Development with Therapeutic Potential for COVID-19</title>
 </caption>
 <table frame="hsides" rules="groups" border="0">
  <colgroup>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
  </colgroup>
  <thead>
   <tr>
    <th style="border:none;" align="center">CAS RN</th>
    <th style="border:none;" align="center">small molecule compound</th>
    <th style="border:none;" align="center">target</th>
    <th style="border:none;" align="center">possible mechanism of action on COVID-19</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td style="border:none;" align="left">4431-00-9</td>
    <td style="border:none;" align="left">aurine tricarboxylic acid</td>
    <td style="border:none;" align="left">RNA-dependent RNA polymerase (RdRp)</td>
    <td style="border:none;" align="left">an inhibitor that may bind to viral RdRp, as tested against SARS-CoV in cell culture
     <sup>
      <xref ref-type="bibr" rid="ref16">16</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">502960-90-9</td>
    <td style="border:none;" align="left">4-methyl-
     <italic>N</italic>-[(1
     <italic>S</italic>)-2-oxo-2 [[(1
     <italic>S</italic>,2
     <italic>E</italic>)-1-(2-phenylethyl)-3-(phenylsulfonyl)-2-propen-1-yl]amino]-1-(phenylmethyl)ethyl]- 1-piperazinecarboxamide
    </td>
    <td style="border:none;" align="left">viral proteases: 3CLpro and PLpro</td>
    <td style="border:none;" align="left">an inhibitor that may disrupt the function of 3CLpro and PLpro, which was tested against SARS-CoV
     <sup>
      <xref ref-type="bibr" rid="ref16">16</xref>,
      <xref ref-type="bibr" rid="ref39">39</xref>,
      <xref ref-type="bibr" rid="ref40">40</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">1851279-09-8</td>
    <td style="border:none;" align="left">4-(1,1-dimethylethyl)-
     <italic>N</italic>-[(1
     <italic>S</italic>)-2-oxo-2-[[(1
     <italic>S</italic>,2
     <italic>E</italic>)-1-(2-phenylethyl)-3-(phenylsulfonyl)-2-propen-1-yl]amino]-1-(phenylmethyl)ethyl]- 1-piperazinecarboxamide
    </td>
    <td style="border:none;" align="left"> </td>
    <td style="border:none;" align="left"> </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">1851280-00-6</td>
    <td style="border:none;" align="left">4-(2-methoxyethyl)-
     <italic>N</italic>-[(1
     <italic>S</italic>)-2-oxo-2-[[(1
     <italic>S</italic>,2
     <italic>E</italic>)-1-(2-phenylethyl)-3-(phenylsulfonyl)-2-propen-1-yl]amino]-1-(phenylmethyl)ethyl]- 1-piperazinecarboxamide
    </td>
    <td style="border:none;" align="left"> </td>
    <td style="border:none;" align="left"> </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">223537-30-2</td>
    <td style="border:none;" align="left">rupintrivir</td>
    <td style="border:none;" align="left"> </td>
    <td style="border:none;" align="left">a cysteine protease inhibitor that may disrupt the function of 3CLpro and PLpro
     <sup>
      <xref ref-type="bibr" rid="ref41">41</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">2409054-43-7</td>
    <td style="border:none;" align="left">(α
     <italic>R</italic>)-α-[[3-(4-chloro-2-fluorophenyl)-1-oxo-2-propen-1-yl]amino]-
     <italic>N</italic>-[(1
     <italic>R</italic>)-1-methyl-2-(2-oxo-3-pyrrolidinyl)ethyl]- benzenepropanamide
    </td>
    <td style="border:none;" align="left">viral proteases: 3CLpro or PLpro</td>
    <td style="border:none;" align="left">an inhibitor that may disrupt the function of 3CLpro or PLpro, as tested against SARS-CoV or MERS-CoV
     <sup>
      <xref ref-type="bibr" rid="ref39">39</xref>,
      <xref ref-type="bibr" rid="ref40">40</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">452088-38-9</td>
    <td style="border:none;" align="left">5-[(4-methyl-1-piperidinyl)sulfonyl]-1
     <italic>H</italic>-indole-2,3-dione
    </td>
    <td style="border:none;" align="left"> </td>
    <td style="border:none;" align="left"> </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">2409054-44-8</td>
    <td style="border:none;" align="left">3-hydroperoxy-4-[2-hydroxy-3-[3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-6-methoxyphenyl]-2-butanone</td>
    <td style="border:none;" align="left"> </td>
    <td style="border:none;" align="left"> </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">41137-87-5</td>
    <td style="border:none;" align="left">hirsutenone</td>
    <td style="border:none;" align="left"> </td>
    <td style="border:none;" align="left"> </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">992-59-6</td>
    <td style="border:none;" align="left">benzopurpurin B</td>
    <td style="border:none;" align="left">NSP15 (poly(U)-specific endoribonuclease)</td>
    <td style="border:none;" align="left">chemical inhibitors that may suppress viral infectivity by inhibiting endoribonuclease NSP15, as tested against SARS-CoV in cultured cells
     <sup>
      <xref ref-type="bibr" rid="ref38">38</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">351891-58-2</td>
    <td style="border:none;" align="left">C-467929</td>
    <td style="border:none;" align="left"> </td>
    <td style="border:none;" align="left"> </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">331675-78-6</td>
    <td style="border:none;" align="left">C-473872</td>
    <td style="border:none;" align="left"> </td>
    <td style="border:none;" align="left"> </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">813419-93-1</td>
    <td style="border:none;" align="left">NSC-306711</td>
    <td style="border:none;" align="left"> </td>
    <td style="border:none;" align="left"> </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">501444-06-0</td>
    <td style="border:none;" align="left">N-65828</td>
    <td style="border:none;" align="left"> </td>
    <td style="border:none;" align="left"> </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">477775-14-7</td>
    <td style="border:none;" align="left">C-21</td>
    <td style="border:none;" align="left">AT2</td>
    <td style="border:none;" align="left">an angiotensin AT2 receptor agonist that may alleviate the virus-induced lung injury
     <sup>
      <xref ref-type="bibr" rid="ref24">24</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">127060-75-7</td>
    <td style="border:none;" align="left">CGP-42112A</td>
    <td style="border:none;" align="left"> </td>
    <td style="border:none;" align="left"> </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">170969-73-0</td>
    <td style="border:none;" align="left">L-163491</td>
    <td style="border:none;" align="left"> </td>
    <td style="border:none;" align="left">a dual-property molecule that functions as angiotensin AT1 partial antagonist and AT2 agonist which may alleviate the virus-induced lung injury
     <sup>
      <xref ref-type="bibr" rid="ref24">24</xref>
     </sup>
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
